INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,107 | -52.4% | 13,545 | -9.4% | 0.00% | 0.0% |
| Q4 2022 | $23,333 | -9.6% | 14,957 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $25,801 | +88.0% | 14,957 | +88.5% | 0.00% | 0.0% |
| Q2 2022 | $13,726 | -71.5% | 7,934 | -40.9% | 0.00% | -50.0% |
| Q1 2022 | $48,217 | -79.6% | 13,431 | -71.6% | 0.00% | -33.3% |
| Q4 2021 | $236,262 | -30.5% | 47,347 | -0.3% | 0.00% | -40.0% |
| Q3 2021 | $340,121 | -32.3% | 47,503 | -12.4% | 0.01% | -28.6% |
| Q2 2021 | $502,629 | +8.2% | 54,221 | +8.3% | 0.01% | 0.0% |
| Q1 2021 | $464,548 | +13.0% | 50,059 | +7.8% | 0.01% | +16.7% |
| Q4 2020 | $411,127 | -21.7% | 46,455 | +2.6% | 0.01% | -33.3% |
| Q3 2020 | $525,318 | -55.4% | 45,286 | +3.6% | 0.01% | -57.1% |
| Q2 2020 | $1,177,877 | +428.3% | 43,706 | +45.8% | 0.02% | +320.0% |
| Q1 2020 | $222,962 | +103.3% | 29,968 | -9.8% | 0.01% | +150.0% |
| Q4 2019 | $109,666 | +612.4% | 33,232 | +342.6% | 0.00% | – |
| Q3 2019 | $15,393 | -82.1% | 7,509 | -74.4% | 0.00% | -100.0% |
| Q2 2019 | $86,118 | -21.2% | 29,292 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $109,259 | -4.3% | 29,292 | +2.7% | 0.00% | 0.0% |
| Q4 2018 | $114,120 | -28.1% | 28,530 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $158,627 | -99.9% | 28,530 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $111,837,000 | -5.8% | 28,530 | +13.2% | 0.00% | 0.0% |
| Q1 2018 | $118,701,000 | +169472.9% | 25,202 | +49.7% | 0.00% | +100.0% |
| Q4 2017 | $70,000 | -79.0% | 16,831 | -68.0% | 0.00% | -50.0% |
| Q3 2017 | $333,000 | -17.6% | 52,531 | +1.9% | 0.00% | -33.3% |
| Q2 2017 | $404,000 | +18.5% | 51,573 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $341,000 | +3.3% | 51,573 | +8.5% | 0.00% | 0.0% |
| Q4 2016 | $330,000 | -31.5% | 47,553 | -8.1% | 0.00% | -50.0% |
| Q3 2016 | $482,000 | -1.4% | 51,769 | -2.2% | 0.00% | 0.0% |
| Q2 2016 | $489,000 | +6.1% | 52,957 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $461,000 | +29.5% | 52,957 | 0.0% | 0.00% | +33.3% |
| Q4 2015 | $356,000 | +16.3% | 52,957 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $306,000 | -30.5% | 52,957 | -1.8% | 0.00% | -33.3% |
| Q2 2015 | $440,000 | +2.1% | 53,941 | +15.0% | 0.00% | 0.0% |
| Q4 2014 | $431,000 | +4.1% | 46,914 | +11.5% | 0.00% | 0.0% |
| Q3 2014 | $414,000 | -30.8% | 42,067 | -23.9% | 0.00% | -25.0% |
| Q2 2014 | $598,000 | – | 55,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |